Paul Silva Net Worth & Insider Trades
Paul Silva - SVP & Chief Accounting Officer, Vertex Pharmaceuticals Inc / Ma
What is Paul Silva's Net Worth?
The current estimated net worth of Vertex Pharmaceuticals Inc / Ma's SVP & Chief Accounting Officer, Paul Silva, is estimated to be about $57.5M . Paul Silva owns about 10,053 units of Vertex Pharmaceuticals Inc / Ma common stock. In the last 13 years at Vertex Pharmaceuticals Inc / Ma, Paul Silva has sold an estimated value of $54.09M worth.
What is Paul Silva's Past Insider Trading?
Paul Silva's largest purchase order was 40,006 units , worth over $3.04M on July 21, 2017. Paul Silva's largest sale order was 43,443 units , worth over $7M on July 21, 2017. In total, Paul Silva has made about 126 transactions over 13 years of their time at Vertex Pharmaceuticals Inc / Ma. Paul Silva usually trades in February, with the busiest year in 2015. The most recent transaction was a sale order of 5,000 units , worth over $1.06M on March 2, 2021.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Paul Silva
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Paul Silva's' Mailing Address?
- Mailing address is C/o Vertex Pharmaceuticals Incorporated 130 Waverly St Cambridge MA 02139 MA
What are Vertex Pharmaceuticals Inc / Ma's Past Insider Trades?
Vertex Pharmaceuticals Inc / Ma's most recent insider trade came on November 21, 2023 by Charles Wagner Jr who sold 3,000 units worth $1.05M . In the last 20 years, insiders at Vertex Pharmaceuticals Inc / Ma have sold an estimated value of $1.81B and bought an estimated value of $541.77M worth of shares. Insider trading is most common in February, with the busiest year in 2015. The most active traders at the company are Joshua Boger, Director, Paul Silva, SVP & Chief Accounting Officer, and Amit Sachdev, EVP Chief Patient & Ext Af Off .
VERTEX PHARMACEUTICALS INC / MA Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||